Mice Model Market size is expected to grow at a CAGR of 6.8% during the forecast period and the market size is expected to reach nearly USD 2.34 Billion by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Mice Model Market Dynamics:
Growing innovations in the mice models and the increasing demand for personalized medicines across the globe are some of the driving factors behind the global mice model market during the forecast period. Additionally, a substantial rise in the number of research and development activities in the pharmaceutical sector is expected to contribute enormously towards the growth of the global mice model market during the forecast period. On the other hand, the increasing use of rat models for several research activities and the growing welfares from cryopreservation are expected to limit the growth of the global market. Furthermore, the growing number of advanced mice models is expected to increase the acceptability and applicability during the forecast period, which is expected to increase the global market growth. The introduction of CRISPR, which is being used as a robust tool in biomedical research and the increasing demand for humanized mice models are also expected to boost the growth of the global market. A considerable rise in the monoclonal antibody production is expected to contribute towards the development of the global market. The knockout mice models are projected to grow at the xx % rate of CAGR during the forecast period. The growth in the market can be attributed to the popularity of CRISPR Technology for producing gene knockouts, high investments in the development of new and innovative knockout models, which also raises the application areas for these models. The breeding services segment is expected to hold a dominant position in the global market. The dominant position in the market can be attributed to the rising need for expertise in breeding mutant, transgenic, gene-targeted, and other types of mice, causing in growth in demand for breeding services among biomedical and pharmaceutical researchers. CRISPR-Cas9 is the technology of the mice model, which is expected to contribute a significant share in the global market. The appearance of CRISPR-Cas9 gene-editing technology delivers features like simplicity, versatility, and efficiency over improved the time frame. The technology has empowered rapid production of knockout, conditional alleles or mice carrying single point mutations, which imitator those in human patients. The CRISPR-Cas9 has rapidly become the preferred technology for genetic manipulation and appearances incredible promise as a platform for studying gene function in vivo. North America region is estimated to dominate the global market. The dominant position in the market is attributed to the presence of a significant patient pool, particularly in rural/remote areas with limited healthcare access, an aging population, and an increasing burden of chronic diseases like diabetes and cardiovascular diseases. On the other hand, the Asia Pacific region is projected to be a leading region in the global market. Huge population base and growing patient pool with chronic diseases, which requires extensive treatment for the prevention of such diseases, innovation in biological research owing to huge government funding, and well-established research laboratories in the developing countries are some of the prominent factors behind the market growth in the region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the global market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market.Mice Model Market, Key Highlights:
Global Mice Model Market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Mice Model Market Mice Model Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. Global Mice Model Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global Mice Model Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Mice Model Market are also profiled.Mice Model Market Scope: Inquire before buying
Mice Model Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.47 Bn. Forecast Period 2023 to 2029 CAGR: 6.8% Market Size in 2029: US $ 2.34 Bn. Segments Covered: by Product Primary Cells Fat Blood Nerve Bone Endothelial Stem Muscle Skin Others Reagents and supplements Attachment Solutions Buffers and Salts Freezing Media Sera Growth Factors and Cytokines Others Media Blood Cells Media Fat Cells Media Bone Cells Media Nerve Cells Media Skin Cells Media Muscle Cells Media Stem Cells Media Others by Model Type Outbred Mice Inbred Mice Knockout/Genetically Modified Mice Hybrid/Congenic Mice Conditioned/Surgically Modified Mice Immunodeficient Mice by Service Breeding Cryopreservation Quarantine Rederivation Model-in-licensing Genetic Testing Other Services by Technology CRISPR/CAS9 Microinjection Embryonic Stem Cell Injection Nuclear Transfer Other Technologies by Care Product Cages Feed Bedding Other Care Products by Application Oncology Immunology and Inflammation Daibetes Cardiovascular Studies Neurology Other Applications Mice Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Key Player:
1. ENVIGO 2. Laboratory Corporation of America Holdings 3. Janvier Labs 4. Harbour Antibodies Bv 5. Trans Genic, Inc. 6. Charles River Laboratories International, Inc. 7. The Jackson Laboratory 8. Taconic Biosciences, Inc. 9. Genoway 10. Horizon Discovery Group PLC. 11. Ingenious Targeting Laboratory 12. PolyGene 13. Crown Biosciences 14. TransCure bioservices 15. Cyagen Biosciences 16. GVK BIO 17. The Andersons, Inc. 18. Innovive 19. Allentown, LLC 20. FENGSHI Group 21. Ozgene Pty Ltd. 22. Harbour Biomed Frequently Asked Questions: 1. Which region has the largest share in Global Mice Model Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Mice Model Market? Ans: The Global Mice Model Market is growing at a CAGR of 6.8% during forecasting period 2023-2029. 3. What is scope of the Global Mice Model market report? Ans: Global Mice Model Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Mice Model market? Ans: The important key players in the Global Mice Model Market are –ENVIGO, Laboratory Corporation of America Holdings, Janvier Labs, Harbour Antibodies Bv, Trans Genic, Inc., Charles River Laboratories International, Inc., 5. What is the study period of this market? Ans: The Global Mice Model Market is studied from 2022 to 2029.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Mice Model Market Size, by Market Value (US$ Bn ) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Mice Model Market and Emerging Technologies 4.8. Global Mice Model Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Mice Model Market Analysis and Forecast 6.1. Global Mice Model Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Mice Model Market Analysis and Forecast, by Model Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Mice Model Market Value Share Analysis, by Model Type 7.4. Global Mice Model Market Size (US$ Bn ) Forecast, by Model Type 7.5. Global Mice Model Market Analysis, by Model Type 7.6. Global Mice Model Market Attractiveness Analysis, by Model Type 8. Global Mice Model Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Mice Model Market Value Share Analysis, by Technology 8.4. Global Mice Model Market Size (US$ Bn ) Forecast, by Technology 8.5. Global Mice Model Market Analysis, by Technology 8.6. Global Mice Model Market Attractiveness Analysis, by Technology 9. Global Mice Model Market Analysis and Forecast, by Service 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Mice Model Market Value Share Analysis, by Service 9.4. Global Mice Model Market Size (US$ Bn ) Forecast, by Service 9.5. Global Mice Model Market Analysis, by Service 9.6. Global Mice Model Market Attractiveness Analysis, by Service 10. Global Mice Model Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Mice Model Market Value Share Analysis, by Application 10.4. Global Mice Model Market Size (US$ Bn ) Forecast, by Application 10.5. Global Mice Model Market Analysis, by Application 10.6. Global Mice Model Market Attractiveness Analysis, by Application 11. Global Mice Model Market Analysis and Forecast, by Care Product 11.1. Introduction and Definition 11.2. Key Findings 11.3. Global Mice Model Market Value Share Analysis, by Care Product 11.4. Global Mice Model Market Size (US$ Bn ) Forecast, by Care Product 11.5. Global Mice Model Market Analysis, by Care Product 11.6. Global Mice Model Market Attractiveness Analysis, by Care Product 12. Global Mice Model Market Analysis, by Region 12.1. Global Mice Model Market Value Share Analysis, by Region 12.2. Global Mice Model Market Size (US$ Bn ) Forecast, by Region 12.3. Global Mice Model Market Attractiveness Analysis, by Region 13. North America Mice Model Market Analysis 13.1. Key Findings 13.2. North America Mice Model Market Overview 13.3. North America Mice Model Market Value Share Analysis, by Model Type 13.4. North America Mice Model Market Forecast, by Model Type 13.4.1. Outbred Mice 13.4.2. Inbred Mice 13.4.3. Knockout/Genetically Modified Mice 13.4.4. Hybrid/Congenic Mice 13.4.5. Conditioned/Surgically Modified Mice 13.4.6. Immunodeficient Mice 13.5. North America Mice Model Market Value Share Analysis, by Technology 13.6. North America Mice Model Market Forecast, by Technology 13.6.1. CRISPR/CAS9 13.6.2. Microinjection 13.6.3. Embryonic Stem Cell Injection 13.6.4. Nuclear Transfer 13.6.5. Other Technologies 13.7. North America Mice Model Market Value Share Analysis, by Service 13.8. North America Mice Model Market Forecast, by Service 13.8.1. Breeding 13.8.2. Cryopreservation 13.8.3. Quarantine 13.8.4. Rederivation 13.8.5. Model-in-licensing 13.8.6. Genetic Testing 13.8.7. Other Services 13.9. North America Mice Model Market Value Share Analysis, by Application 13.10. North America Mice Model Market Forecast, by Application 13.10.1. Oncology 13.10.2. Immunology and Inflammation 13.10.3. Daibetes 13.10.4. Cardiovascular Studies 13.10.5. Neurology 13.10.6. Other Applications 13.11. North America Mice Model Market Value Share Analysis, by Care Product 13.12. North America Mice Model Market Forecast, by Care Product 13.12.1. Cages 13.12.2. Feed 13.12.3. Bedding 13.12.4. Other Care Products 13.13. North America Mice Model Market Value Share Analysis, by Country 13.14. North America Mice Model Market Forecast, by Country 13.14.1. U.S. 13.14.2. Canada 13.15. North America Mice Model Market Analysis, by Country 13.16. U.S. Mice Model Market Forecast, by Model Type 13.16.1. Outbred Mice 13.16.2. Inbred Mice 13.16.3. Knockout/Genetically Modified Mice 13.16.4. Hybrid/Congenic Mice 13.16.5. Conditioned/Surgically Modified Mice 13.16.6. Immunodeficient Mice 13.17. U.S. Mice Model Market Forecast, by Technology 13.17.1. CRISPR/CAS9 13.17.2. Microinjection 13.17.3. Embryonic Stem Cell Injection 13.17.4. Nuclear Transfer 13.17.5. Other Technologies 13.18. U.S. Mice Model Market Forecast, by Service 13.18.1. Breeding 13.18.2. Cryopreservation 13.18.3. Quarantine 13.18.4. Rederivation 13.18.5. Model-in-licensing 13.18.6. Genetic Testing 13.18.7. Other Services 13.19. U.S. Mice Model Market Forecast, by Application 13.19.1. Oncology 13.19.2. Immunology and Inflammation 13.19.3. Daibetes 13.19.4. Cardiovascular Studies 13.19.5. Neurology 13.19.6. Other Applications 13.20. U.S. Mice Model Market Forecast, by Care Product 13.20.1. Cages 13.20.2. Feed 13.20.3. Bedding 13.20.4. Other Care Products 13.21. Canada Mice Model Market Forecast, by Model Type 13.21.1. Outbred Mice 13.21.2. Inbred Mice 13.21.3. Knockout/Genetically Modified Mice 13.21.4. Hybrid/Congenic Mice 13.21.5. Conditioned/Surgically Modified Mice 13.21.6. Immunodeficient Mice 13.22. Canada Mice Model Market Forecast, by Technology 13.22.1. CRISPR/CAS9 13.22.2. Microinjection 13.22.3. Embryonic Stem Cell Injection 13.22.4. Nuclear Transfer 13.22.5. Other Technologies 13.23. Canada Mice Model Market Forecast, by Service 13.23.1. Breeding 13.23.2. Cryopreservation 13.23.3. Quarantine 13.23.4. Rederivation 13.23.5. Model-in-licensing 13.23.6. Genetic Testing 13.23.7. Other Services 13.24. Canada Mice Model Market Forecast, by Application 13.24.1. Oncology 13.24.2. Immunology and Inflammation 13.24.3. Daibetes 13.24.4. Cardiovascular Studies 13.24.5. Neurology 13.24.6. Other Applications 13.25. Canada Mice Model Market Forecast, by Care Product 13.25.1. Cages 13.25.2. Feed 13.25.3. Bedding 13.25.4. Other Care Products 13.26. North America Mice Model Market Attractiveness Analysis 13.26.1. By Model Type 13.26.2. By Technology 13.26.3. By Service 13.26.4. By Application 13.26.5. By Care Product 13.27. PEST Analysis 13.28. Key Trends 13.29. Key Developments 14. Europe Mice Model Market Analysis 14.1. Key Findings 14.2. Europe Mice Model Market Overview 14.3. Europe Mice Model Market Value Share Analysis, by Model Type 14.4. Europe Mice Model Market Forecast, by Model Type 14.4.1. Outbred Mice 14.4.2. Inbred Mice 14.4.3. Knockout/Genetically Modified Mice 14.4.4. Hybrid/Congenic Mice 14.4.5. Conditioned/Surgically Modified Mice 14.4.6. Immunodeficient Mice 14.5. Europe Mice Model Market Value Share Analysis, by Technology 14.6. Europe Mice Model Market Forecast, by Technology 14.6.1. CRISPR/CAS9 14.6.2. Microinjection 14.6.3. Embryonic Stem Cell Injection 14.6.4. Nuclear Transfer 14.6.5. Other Technologies 14.7. Europe Mice Model Market Value Share Analysis, by Service 14.8. Europe Mice Model Market Forecast, by Service 14.8.1. Breeding 14.8.2. Cryopreservation 14.8.3. Quarantine 14.8.4. Rederivation 14.8.5. Model-in-licensing 14.8.6. Genetic Testing 14.8.7. Other Technology 14.9. Europe Mice Model Market Value Share Analysis, by Application 14.10. Europe Mice Model Market Forecast, by Application 14.10.1. Oncology 14.10.2. Immunology and Inflammation 14.10.3. Daibetes 14.10.4. Cardiovascular Studies 14.10.5. Neurology 14.10.6. Other Applications 14.11. Europe Mice Model Market Value Share Analysis, by Care Product 14.12. Europe Mice Model Market Forecast, by Care Product 14.12.1. Cages 14.12.2. Feed 14.12.3. Bedding 14.12.4. Other Care Products 14.13. Europe Mice Model Market Value Share Analysis, by Country 14.14. Europe Mice Model Market Forecast, by Country 14.14.1. Germany 14.14.2. U.K. 14.14.3. France 14.14.4. Italy 14.14.5. Spain 14.14.6. Rest of Europe 14.15. Europe Mice Model Market Analysis, by Country 14.16. Germany Mice Model Market Forecast, by Model Type 14.16.1. Outbred Mice 14.16.2. Inbred Mice 14.16.3. Knockout/Genetically Modified Mice 14.16.4. Hybrid/Congenic Mice 14.16.5. Conditioned/Surgically Modified Mice 14.16.6. Immunodeficient Mice 14.17. Germany Mice Model Market Forecast, by Technology 14.17.1. CRISPR/CAS9 14.17.2. Microinjection 14.17.3. Embryonic Stem Cell Injection 14.17.4. Nuclear Transfer 14.17.5. Other Technologies 14.18. Germany Mice Model Market Forecast, by Service 14.18.1. Breeding 14.18.2. Cryopreservation 14.18.3. Quarantine 14.18.4. Rederivation 14.18.5. Model-in-licensing 14.18.6. Genetic Testing 14.18.7. Other Services 14.19. Germany Mice Model Market Forecast, by Application 14.19.1. Oncology 14.19.2. Immunology and Inflammation 14.19.3. Daibetes 14.19.4. Cardiovascular Studies 14.19.5. Neurology 14.19.6. Other Applications 14.20. Germany Mice Model Market Forecast, by Care Product 14.20.1. Cages 14.20.2. Feed 14.20.3. Bedding 14.20.4. Other Care Products 14.21. U.K. Mice Model Market Forecast, by Model Type 14.21.1. Outbred Mice 14.21.2. Inbred Mice 14.21.3. Knockout/Genetically Modified Mice 14.21.4. Hybrid/Congenic Mice 14.21.5. Conditioned/Surgically Modified Mice 14.21.6. Immunodeficient Mice 14.22. U.K. Mice Model Market Forecast, by Technology 14.22.1. CRISPR/CAS9 14.22.2. Microinjection 14.22.3. Embryonic Stem Cell Injection 14.22.4. Nuclear Transfer 14.22.5. Other Technologies 14.23. U.K. Mice Model Market Forecast, by Service 14.23.1. Breeding 14.23.2. Cryopreservation 14.23.3. Quarantine 14.23.4. Rederivation 14.23.5. Model-in-licensing 14.23.6. Genetic Testing 14.23.7. Other Services 14.24. U.K. Mice Model Market Forecast, by Application 14.24.1. Oncology 14.24.2. Immunology and Inflammation 14.24.3. Daibetes 14.24.4. Cardiovascular Studies 14.24.5. Neurology 14.24.6. Other Applications 14.25. U.K. Mice Model Market Forecast, by Care Product 14.25.1. Cages 14.25.2. Feed 14.25.3. Bedding 14.25.4. Other Care Products 14.26. France Mice Model Market Forecast, by Model Type 14.26.1. Outbred Mice 14.26.2. Inbred Mice 14.26.3. Knockout/Genetically Modified Mice 14.26.4. Hybrid/Congenic Mice 14.26.5. Conditioned/Surgically Modified Mice 14.26.6. Immunodeficient Mice 14.27. France Mice Model Market Forecast, by Technology 14.27.1. CRISPR/CAS9 14.27.2. Microinjection 14.27.3. Embryonic Stem Cell Injection 14.27.4. Nuclear Transfer 14.27.5. Other Technologies 14.28. France Mice Model Market Forecast, by Service 14.28.1. Breeding 14.28.2. Cryopreservation 14.28.3. Quarantine 14.28.4. Rederivation 14.28.5. Model-in-licensing 14.28.6. Genetic Testing 14.28.7. Other Services 14.29. France Mice Model Market Forecast, by Application 14.29.1. Oncology 14.29.2. Immunology and Inflammation 14.29.3. Daibetes 14.29.4. Cardiovascular Studies 14.29.5. Neurology 14.29.6. Other Applications 14.30. France Mice Model Market Forecast, by Care Product 14.30.1. Cages 14.30.2. Feed 14.30.3. Bedding 14.30.4. Other Care Products 14.31. Italy Mice Model Market Forecast, by Model Type 14.31.1. Outbred Mice 14.31.2. Inbred Mice 14.31.3. Knockout/Genetically Modified Mice 14.31.4. Hybrid/Congenic Mice 14.31.5. Conditioned/Surgically Modified Mice 14.31.6. Immunodeficient Mice 14.32. Italy Mice Model Market Forecast, by Technology 14.32.1. CRISPR/CAS9 14.32.2. Microinjection 14.32.3. Embryonic Stem Cell Injection 14.32.4. Nuclear Transfer 14.32.5. Other Technologies 14.33. Italy Mice Model Market Forecast, by Service 14.33.1. Breeding 14.33.2. Cryopreservation 14.33.3. Quarantine 14.33.4. Rederivation 14.33.5. Model-in-licensing 14.33.6. Genetic Testing 14.33.7. Other Services 14.34. Italy Mice Model Market Forecast, by Application 14.34.1. Oncology 14.34.2. Immunology and Inflammation 14.34.3. Daibetes 14.34.4. Cardiovascular Studies 14.34.5. Neurology 14.34.6. Other Applications 14.35. Italy Mice Model Market Forecast, by Care Product 14.35.1. Cages 14.35.2. Feed 14.35.3. Bedding 14.35.4. Other Care Products 14.36. Spain Mice Model Market Forecast, by Model Type 14.36.1. Outbred Mice 14.36.2. Inbred Mice 14.36.3. Knockout/Genetically Modified Mice 14.36.4. Hybrid/Congenic Mice 14.36.5. Conditioned/Surgically Modified Mice 14.36.6. Immunodeficient Mice 14.37. Spain Mice Model Market Forecast, by Technology 14.37.1. CRISPR/CAS9 14.37.2. Microinjection 14.37.3. Embryonic Stem Cell Injection 14.37.4. Nuclear Transfer 14.37.5. Other Technologies 14.38. Spain Mice Model Market Forecast, by Service 14.38.1. Breeding 14.38.2. Cryopreservation 14.38.3. Quarantine 14.38.4. Rederivation 14.38.5. Model-in-licensing 14.38.6. Genetic Testing 14.38.7. Other Services 14.39. Spain Mice Model Market Forecast, by Application 14.39.1. Oncology 14.39.2. Immunology and Inflammation 14.39.3. Daibetes 14.39.4. Cardiovascular Studies 14.39.5. Neurology 14.39.6. Other Applications 14.40. Spain Mice Model Market Forecast, by Care Product 14.40.1. Cages 14.40.2. Feed 14.40.3. Bedding 14.40.4. Other Care Products 14.41. Rest of Europe Mice Model Market Forecast, by Model Type 14.41.1. Outbred Mice 14.41.2. Inbred Mice 14.41.3. Knockout/Genetically Modified Mice 14.41.4. Hybrid/Congenic Mice 14.41.5. Conditioned/Surgically Modified Mice 14.41.6. Immunodeficient Mice 14.42. Rest of Europe Mice Model Market Forecast, by Technology 14.42.1. CRISPR/CAS9 14.42.2. Microinjection 14.42.3. Embryonic Stem Cell Injection 14.42.4. Nuclear Transfer 14.42.5. Other Technologies 14.43. Rest of Europe Mice Model Market Forecast, by Service 14.43.1. Breeding 14.43.2. Cryopreservation 14.43.3. Quarantine 14.43.4. Rederivation 14.43.5. Model-in-licensing 14.43.6. Genetic Testing 14.43.7. Other Services 14.44. Rest Of Europe Mice Model Market Forecast, by Application 14.44.1. Oncology 14.44.2. Immunology and Inflammation 14.44.3. Daibetes 14.44.4. Cardiovascular Studies 14.44.5. Neurology 14.44.6. Other Applications 14.45. Rest Of Europe Mice Model Market Forecast, by Care Product 14.45.1. Cages 14.45.2. Feed 14.45.3. Bedding 14.45.4. Other Care Products 14.46. Europe Mice Model Market Attractiveness Analysis 14.46.1. By Model Type 14.46.2. By Technology 14.46.3. By Service 14.46.4. By Application 14.46.5. By Care Product 14.47. PEST Analysis 14.48. Key Trends 14.49. Key Developments 15. Asia Pacific Mice Model Market Analysis 15.1. Key Findings 15.2. Asia Pacific Mice Model Market Overview 15.3. Asia Pacific Mice Model Market Value Share Analysis, by Model Type 15.4. Asia Pacific Mice Model Market Forecast, by Model Type 15.4.1. Outbred Mice 15.4.2. Inbred Mice 15.4.3. Knockout/Genetically Modified Mice 15.4.4. Hybrid/Congenic Mice 15.4.5. Conditioned/Surgically Modified Mice 15.4.6. Immunodeficient Mice 15.5. Asia Pacific Mice Model Market Value Share Analysis, by Technology 15.6. Asia Pacific Mice Model Market Forecast, by Technology 15.6.1. CRISPR/CAS9 15.6.2. Microinjection 15.6.3. Embryonic Stem Cell Injection 15.6.4. Nuclear Transfer 15.6.5. Other Technologies 15.7. Asia Pacific Mice Model Market Value Share Analysis, by Service 15.8. Asia Pacific Mice Model Market Forecast, by Service 15.8.1. Breeding 15.8.2. Cryopreservation 15.8.3. Quarantine 15.8.4. Rederivation 15.8.5. Model-in-licensing 15.8.6. Genetic Testing 15.8.7. Other Services 15.9. Asia Pacific Mice Model Market Value Share Analysis, by Application 15.10. Asia Pacific Mice Model Market Forecast, by Application 15.10.1. Oncology 15.10.2. Immunology and Inflammation 15.10.3. Daibetes 15.10.4. Cardiovascular Studies 15.10.5. Neurology 15.10.6. Other Applications 15.11. Asia Pacific Mice Model Market Value Share Analysis, by Care Product 15.12. Asia Pacific Mice Model Market Forecast, by Care Product 15.12.1. Cages 15.12.2. Feed 15.12.3. Bedding 15.12.4. Other Care Products 15.13. Asia Pacific Mice Model Market Value Share Analysis, by Country 15.14. Asia Pacific Mice Model Market Forecast, by Country 15.14.1. China 15.14.2. India 15.14.3. Japan 15.14.4. ASEAN 15.14.5. Rest of Asia Pacific 15.15. Asia Pacific Mice Model Market Analysis, by Country 15.16. China Mice Model Market Forecast, by Model Type 15.16.1. Outbred Mice 15.16.2. Inbred Mice 15.16.3. Knockout/Genetically Modified Mice 15.16.4. Hybrid/Congenic Mice 15.16.5. Conditioned/Surgically Modified Mice 15.16.6. Immunodeficient Mice 15.17. China Mice Model Market Forecast, by Technology 15.17.1. CRISPR/CAS9 15.17.2. Microinjection 15.17.3. Embryonic Stem Cell Injection 15.17.4. Nuclear Transfer 15.17.5. Other Technologies 15.18. China Mice Model Market Forecast, by Service 15.18.1. Breeding 15.18.2. Cryopreservation 15.18.3. Quarantine 15.18.4. Rederivation 15.18.5. Model-in-licensing 15.18.6. Genetic Testing 15.18.7. Other Services 15.19. China Mice Model Market Forecast, by Application 15.19.1. Oncology 15.19.2. Immunology and Inflammation 15.19.3. Daibetes 15.19.4. Cardiovascular Studies 15.19.5. Neurology 15.19.6. Other Applications 15.20. China Mice Model Market Forecast, by Care Product 15.20.1. Cages 15.20.2. Feed 15.20.3. Bedding 15.20.4. Other Care Products 15.21. India Mice Model Market Forecast, by Model Type 15.21.1. Outbred Mice 15.21.2. Inbred Mice 15.21.3. Knockout/Genetically Modified Mice 15.21.4. Hybrid/Congenic Mice 15.21.5. Conditioned/Surgically Modified Mice 15.21.6. Immunodeficient Mice 15.22. India Mice Model Market Forecast, by Technology 15.22.1. CRISPR/CAS9 15.22.2. Microinjection 15.22.3. Embryonic Stem Cell Injection 15.22.4. Nuclear Transfer 15.22.5. Other Technologies 15.23. India Mice Model Market Forecast, by Service 15.23.1. Breeding 15.23.2. Cryopreservation 15.23.3. Quarantine 15.23.4. Rederivation 15.23.5. Model-in-licensing 15.23.6. Genetic Testing 15.23.7. Other Services 15.24. India Mice Model Market Forecast, by Application 15.24.1. Oncology 15.24.2. Immunology and Inflammation 15.24.3. Daibetes 15.24.4. Cardiovascular Studies 15.24.5. Neurology 15.24.6. Other Applications 15.25. India Mice Model Market Forecast, by Care Product 15.25.1. Cages 15.25.2. Feed 15.25.3. Bedding 15.25.4. Other Care Products 15.26. Japan Mice Model Market Forecast, by Model Type 15.26.1. Outbred Mice 15.26.2. Inbred Mice 15.26.3. Knockout/Genetically Modified Mice 15.26.4. Hybrid/Congenic Mice 15.26.5. Conditioned/Surgically Modified Mice 15.26.6. Immunodeficient Mice 15.27. Japan Mice Model Market Forecast, by Technology 15.27.1. CRISPR/CAS9 15.27.2. Microinjection 15.27.3. Embryonic Stem Cell Injection 15.27.4. Nuclear Transfer 15.27.5. Other Technologies 15.28. Japan Mice Model Market Forecast, by Service 15.28.1. Breeding 15.28.2. Cryopreservation 15.28.3. Quarantine 15.28.4. Rederivation 15.28.5. Model-in-licensing 15.28.6. Genetic Testing 15.28.7. Other Services 15.29. Japan Mice Model Market Forecast, by Application 15.29.1. Oncology 15.29.2. Immunology and Inflammation 15.29.3. Daibetes 15.29.4. Cardiovascular Studies 15.29.5. Neurology 15.29.6. Other Applications 15.30. Japan Mice Model Market Forecast, by Care Product 15.30.1. Cages 15.30.2. Feed 15.30.3. Bedding 15.30.4. Other Care Products 15.31. ASEAN Mice Model Market Forecast, by Model Type 15.31.1. Outbred Mice 15.31.2. Inbred Mice 15.31.3. Knockout/Genetically Modified Mice 15.31.4. Hybrid/Congenic Mice 15.31.5. Conditioned/Surgically Modified Mice 15.31.6. Immunodeficient Mice 15.32. ASEAN Mice Model Market Forecast, by Technology 15.32.1. CRISPR/CAS9 15.32.2. Microinjection 15.32.3. Embryonic Stem Cell Injection 15.32.4. Nuclear Transfer 15.32.5. Other Technologies 15.33. ASEAN Mice Model Market Forecast, by Service 15.33.1. Breeding 15.33.2. Cryopreservation 15.33.3. Quarantine 15.33.4. Rederivation 15.33.5. Model-in-licensing 15.33.6. Genetic Testing 15.33.7. Other Services 15.34. ASEAN Mice Model Market Forecast, by Application 15.34.1. Oncology 15.34.2. Immunology and Inflammation 15.34.3. Daibetes 15.34.4. Cardiovascular Studies 15.34.5. Neurology 15.34.6. Other Applications 15.35. ASEAN Mice Model Market Forecast, by Care Product 15.35.1. Cages 15.35.2. Feed 15.35.3. Bedding 15.35.4. Other Care Products 15.36. Rest of Asia Pacific Mice Model Market Forecast, by Model Type 15.36.1. Outbred Mice 15.36.2. Inbred Mice 15.36.3. Knockout/Genetically Modified Mice 15.36.4. Hybrid/Congenic Mice 15.36.5. Conditioned/Surgically Modified Mice 15.36.6. Immunodeficient Mice 15.37. Rest of Asia Pacific Mice Model Market Forecast, by Technology 15.37.1. CRISPR/CAS9 15.37.2. Microinjection 15.37.3. Embryonic Stem Cell Injection 15.37.4. Nuclear Transfer 15.37.5. Other Technologies 15.38. Rest of Asia Pacific Mice Model Market Forecast, by Service 15.38.1. Breeding 15.38.2. Cryopreservation 15.38.3. Quarantine 15.38.4. Rederivation 15.38.5. Model-in-licensing 15.38.6. Genetic Testing 15.38.7. Other Services 15.39. Rest of Asia Pacific Mice Model Market Forecast, by Application 15.39.1. Oncology 15.39.2. Immunology and Inflammation 15.39.3. Daibetes 15.39.4. Cardiovascular Studies 15.39.5. Neurology 15.39.6. Other Applications 15.40. Rest of Asia Pacific Mice Model Market Forecast, by Care Product 15.40.1. Cages 15.40.2. Feed 15.40.3. Bedding 15.40.4. Other Care Products 15.41. Asia Pacific Mice Model Market Attractiveness Analysis 15.41.1. By Model Type 15.41.2. By Technology 15.41.3. By Service 15.41.4. By Application 15.41.5. By Care Product 15.42. PEST Analysis 15.43. Key Trends 15.44. Key Developments 16. Middle East & Africa Mice Model Market Analysis 16.1. Key Findings 16.2. Middle East & Africa Mice Model Market Overview 16.3. Middle East & Africa Mice Model Market Value Share Analysis, by Model Type 16.4. Middle East & Africa Mice Model Market Forecast, by Model Type 16.4.1. Outbred Mice 16.4.2. Inbred Mice 16.4.3. Knockout/Genetically Modified Mice 16.4.4. Hybrid/Congenic Mice 16.4.5. Conditioned/Surgically Modified Mice 16.4.6. Immunodeficient Mice 16.5. Middle East & Africa Mice Model Market Value Share Analysis, by Technology 16.6. Middle East & Africa Mice Model Market Forecast, by Technology 16.6.1. CRISPR/CAS9 16.6.2. Microinjection 16.6.3. Embryonic Stem Cell Injection 16.6.4. Nuclear Transfer 16.6.5. Other Technologies 16.7. Middle East & Africa Mice Model Market Value Share Analysis, by Service 16.8. Middle East & Africa Mice Model Market Forecast, by Service 16.8.1. Breeding 16.8.2. Cryopreservation 16.8.3. Quarantine 16.8.4. Rederivation 16.8.5. Model-in-licensing 16.8.6. Genetic Testing 16.8.7. Other Services 16.9. Middle East & Africa Mice Model Market Value Share Analysis, by Application 16.10. Middle East & Africa Mice Model Market Forecast, by Application 16.10.1. Oncology 16.10.2. Immunology and Inflammation 16.10.3. Daibetes 16.10.4. Cardiovascular Studies 16.10.5. Neurology 16.10.6. Other Applications 16.11. Middle East & Africa Mice Model Market Value Share Analysis, by Care Product 16.12. Middle East & Africa Mice Model Market Forecast, by Care Product 16.12.1. Cages 16.12.2. Feed 16.12.3. Bedding 16.12.4. Other Care Products 16.13. Middle East & Africa Mice Model Market Value Share Analysis, by Country 16.14. Middle East & Africa Mice Model Market Forecast, by Country 16.14.1. GCC 16.14.2. South Africa 16.14.3. Rest of Middle East & Africa 16.15. Middle East & Africa Mice Model Market Analysis, by Country 16.16. GCC Mice Model Market Forecast, by Model Type 16.16.1. Outbred Mice 16.16.2. Inbred Mice 16.16.3. Knockout/Genetically Modified Mice 16.16.4. Hybrid/Congenic Mice 16.16.5. Conditioned/Surgically Modified Mice 16.16.6. Immunodeficient Mice 16.17. GCC Mice Model Market Forecast, by Technology 16.17.1. CRISPR/CAS9 16.17.2. Microinjection 16.17.3. Embryonic Stem Cell Injection 16.17.4. Nuclear Transfer 16.17.5. Other Technologies 16.18. GCC Mice Model Market Forecast, by Service 16.18.1. Breeding 16.18.2. Cryopreservation 16.18.3. Quarantine 16.18.4. Rederivation 16.18.5. Model-in-licensing 16.18.6. Genetic Testing 16.18.7. Other Services 16.19. GCC Mice Model Market Forecast, by Application 16.19.1. Oncology 16.19.2. Immunology and Inflammation 16.19.3. Daibetes 16.19.4. Cardiovascular Studies 16.19.5. Neurology 16.19.6. Other Applications 16.20. GCC Mice Model Market Forecast, by Care Product 16.20.1. Cages 16.20.2. Feed 16.20.3. Bedding 16.20.4. Other Care Products 16.21. South Africa Mice Model Market Forecast, by Model Type 16.21.1. Outbred Mice 16.21.2. Inbred Mice 16.21.3. Knockout/Genetically Modified Mice 16.21.4. Hybrid/Congenic Mice 16.21.5. Conditioned/Surgically Modified Mice 16.21.6. Immunodeficient Mice 16.22. South Africa Mice Model Market Forecast, by Technology 16.22.1. CRISPR/CAS9 16.22.2. Microinjection 16.22.3. Embryonic Stem Cell Injection 16.22.4. Nuclear Transfer 16.22.5. Other Technologies 16.23. South Africa Mice Model Market Forecast, by Service 16.23.1. Breeding 16.23.2. Cryopreservation 16.23.3. Quarantine 16.23.4. Rederivation 16.23.5. Model-in-licensing 16.23.6. Genetic Testing 16.23.7. Other Services 16.24. South Africa Mice Model Market Forecast, by Application 16.24.1. Oncology 16.24.2. Immunology and Inflammation 16.24.3. Daibetes 16.24.4. Cardiovascular Studies 16.24.5. Neurology 16.24.6. Other Applications 16.25. South Africa Mice Model Market Forecast, by Care Product 16.25.1. Cages 16.25.2. Feed 16.25.3. Bedding 16.25.4. Other Care Products 16.26. Rest of Middle East & Africa Mice Model Market Forecast, by Model Type 16.26.1. Outbred Mice 16.26.2. Inbred Mice 16.26.3. Knockout/Genetically Modified Mice 16.26.4. Hybrid/Congenic Mice 16.26.5. Conditioned/Surgically Modified Mice 16.26.6. Immunodeficient Mice 16.27. Rest of Middle East & Africa Mice Model Market Forecast, by Technology 16.27.1. CRISPR/CAS9 16.27.2. Microinjection 16.27.3. Embryonic Stem Cell Injection 16.27.4. Nuclear Transfer 16.27.5. Other Technologies 16.28. Rest of Middle East & Africa Mice Model Market Forecast, by Service 16.28.1. Breeding 16.28.2. Cryopreservation 16.28.3. Quarantine 16.28.4. Rederivation 16.28.5. Model-in-licensing 16.28.6. Genetic Testing 16.28.7. Other Services 16.29. Rest of Middle East & Africa Mice Model Market Forecast, by Application 16.29.1. Oncology 16.29.2. Immunology and Inflammation 16.29.3. Daibetes 16.29.4. Cardiovascular Studies 16.29.5. Neurology 16.29.6. Other Applications 16.30. Rest of Middle East & Africa Mice Model Market Forecast, by Care Product 16.30.1. Cages 16.30.2. Feed 16.30.3. Bedding 16.30.4. Other Care Products 16.31. Middle East & Africa Mice Model Market Attractiveness Analysis 16.31.1. By Model Type 16.31.2. By Technology 16.31.3. By Service 16.31.4. By Application 16.31.5. By Care Product 16.32. PEST Analysis 16.33. Key Trends 16.34. Key Developments 17. South America Mice Model Market Analysis 17.1. Key Findings 17.2. South America Mice Model Market Overview 17.3. South America Mice Model Market Value Share Analysis, by Model Type 17.4. South America Mice Model Market Forecast, by Model Type 17.4.1. Outbred Mice 17.4.2. Inbred Mice 17.4.3. Knockout/Genetically Modified Mice 17.4.4. Hybrid/Congenic Mice 17.4.5. Conditioned/Surgically Modified Mice 17.4.6. Immunodeficient Mice 17.5. South America Mice Model Market Value Share Analysis, by Technology 17.6. South America Mice Model Market Forecast, by Technology 17.6.1. CRISPR/CAS9 17.6.2. Microinjection 17.6.3. Embryonic Stem Cell Injection 17.6.4. Nuclear Transfer 17.6.5. Other Technologies 17.7. South America Mice Model Market Value Share Analysis, by Service 17.8. South America Mice Model Market Forecast, by Service 17.8.1. Breeding 17.8.2. Cryopreservation 17.8.3. Quarantine 17.8.4. Rederivation 17.8.5. Model-in-licensing 17.8.6. Genetic Testing 17.8.7. Other Services 17.9. South America Mice Model Market Value Share Analysis, by Application 17.10. South America Mice Model Market Forecast, by Application 17.10.1. Oncology 17.10.2. Immunology and Inflammation 17.10.3. Daibetes 17.10.4. Cardiovascular Studies 17.10.5. Neurology 17.10.6. Other Applications 17.11. South America Mice Model Market Value Share Analysis, by Care Product 17.12. South America Mice Model Market Forecast, by Care Product 17.12.1. Cages 17.12.2. Feed 17.12.3. Bedding 17.12.4. Other Care Products 17.13. South America Mice Model Market Value Share Analysis, by Country 17.14. South America Mice Model Market Forecast, by Country 17.14.1. Brazil 17.14.2. Mexico 17.14.3. Rest of South America 17.15. South America Mice Model Market Analysis, by Country 17.16. Brazil Mice Model Market Forecast, by Model Type 17.16.1. Outbred Mice 17.16.2. Inbred Mice 17.16.3. Knockout/Genetically Modified Mice 17.16.4. Hybrid/Congenic Mice 17.16.5. Conditioned/Surgically Modified Mice 17.16.6. Immunodeficient Mice 17.17. Brazil Mice Model Market Forecast, by Technology 17.17.1. CRISPR/CAS9 17.17.2. Microinjection 17.17.3. Embryonic Stem Cell Injection 17.17.4. Nuclear Transfer 17.17.5. Other Technologies 17.18. Brazil Mice Model Market Forecast, by Service 17.18.1. Breeding 17.18.2. Cryopreservation 17.18.3. Quarantine 17.18.4. Rederivation 17.18.5. Model-in-licensing 17.18.6. Genetic Testing 17.18.7. Other Services 17.19. Brazil Mice Model Market Forecast, by Application 17.19.1. Oncology 17.19.2. Immunology and Inflammation 17.19.3. Daibetes 17.19.4. Cardiovascular Studies 17.19.5. Neurology 17.19.6. Other Applications 17.20. Brazil Mice Model Market Forecast, by Care Product 17.20.1. Cages 17.20.2. Feed 17.20.3. Bedding 17.20.4. Other Care Products 17.21. Mexico Mice Model Market Forecast, by Model Type 17.21.1. Outbred Mice 17.21.2. Inbred Mice 17.21.3. Knockout/Genetically Modified Mice 17.21.4. Hybrid/Congenic Mice 17.21.5. Conditioned/Surgically Modified Mice 17.21.6. Immunodeficient Mice 17.22. Mexico Mice Model Market Forecast, by Technology 17.22.1. Breeding 17.22.2. Cryopreservation 17.22.3. Quarantine 17.22.4. Rederivation 17.22.5. Model-in-licensing 17.22.6. Genetic Testing 17.22.7. Other Services 17.23. Mexico Mice Model Market Forecast, by Service 17.23.1. Breeding 17.23.2. Cryopreservation 17.23.3. Quarantine 17.23.4. Rederivation 17.23.5. Model-in-licensing 17.23.6. Genetic Testing 17.23.7. Other Services 17.24. Mexico Mice Model Market Forecast, by Application 17.24.1. Oncology 17.24.2. Immunology and Inflammation 17.24.3. Daibetes 17.24.4. Cardiovascular Studies 17.24.5. Neurology 17.24.6. Other Applications 17.25. Mexico Mice Model Market Forecast, by Care Product 17.25.1. Cages 17.25.2. Feed 17.25.3. Bedding 17.25.4. Other Care Products 17.26. Rest of South America Mice Model Market Forecast, by Model Type 17.26.1. Outbred Mice 17.26.2. Inbred Mice 17.26.3. Knockout/Genetically Modified Mice 17.26.4. Hybrid/Congenic Mice 17.26.5. Conditioned/Surgically Modified Mice 17.26.6. Immunodeficient Mice 17.27. Rest of South America Mice Model Market Forecast, by Technology 17.27.1. CRISPR/CAS9 17.27.2. Microinjection 17.27.3. Embryonic Stem Cell Injection 17.27.4. Nuclear Transfer 17.27.5. Other Technologies 17.28. Rest of South America Mice Model Market Forecast, by Service 17.28.1. Breeding 17.28.2. Cryopreservation 17.28.3. Quarantine 17.28.4. Rederivation 17.28.5. Model-in-licensing 17.28.6. Genetic Testing 17.28.7. Other Services 17.29. Rest of South America Mice Model Market Forecast, by Application 17.29.1. Oncology 17.29.2. Immunology and Inflammation 17.29.3. Daibetes 17.29.4. Cardiovascular Studies 17.29.5. Neurology 17.29.6. Other Applications 17.30. Rest of South America Mice Model Market Forecast, by Care Product 17.30.1. Cages 17.30.2. Feed 17.30.3. Bedding 17.30.4. Other Care Products 17.31. South America Mice Model Market Attractiveness Analysis 17.31.1. By Model Type 17.31.2. By Technology 17.31.3. By Service 17.31.4. By Application 17.31.5. By Care Product 17.32. PEST Analysis 17.33. Key Trends 17.34. Key Developments 18. Company Profiles 18.1. Market Share Analysis, by Company 18.2. Competition Matrix 18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 18.2.2. New Product Launches and Product Enhancements 18.2.3. Market Consolidation 18.2.3.1. M&A by Regions, Investment and Applications 18.2.3.2. M&A Key Players, Forward Integration and Backward Integration 18.3. Company Profiles: Key Players 18.3.1. ENVIGO 18.3.1.1. Company Overview 18.3.1.2. Financial Overview 18.3.1.3. Product Portfolio 18.3.1.4. Business Strategy 18.3.1.5. Recent Developments 18.3.1.6. Development Footprint 18.3.2. Laboratory Corporation of America Holdings 18.3.3. Janvier Labs 18.3.4. Harbour Antibodies Bv 18.3.5. Trans Genic, Inc. 18.3.6. Charles River Laboratories International, Inc. 18.3.7. The Jackson Laboratory 18.3.8. Taconic Biosciences, Inc. 18.3.9. Genoway 18.3.10. Horizon Discovery Group PLC. 18.3.11. Ingenious Targeting Laboratory 18.3.12. PolyGene 18.3.13. Crown Biosciences 18.3.14. TransCure bioservices 18.3.15. Cyagen Biosciences 18.3.16. GVK BIO 18.3.17. The Andersons, Inc. 18.3.18. Innovive 18.3.19. Allentown, LLC 18.3.20. FENGSHI Group 18.3.21. Ozgene Pty Ltd. 18.3.22. Harbour Biomed 19. Primary Key Insights